![]() | Digital Bio ExchangeICO DIGITAL BIO EXCHANGE is a platform for easy access to customized health care, personal information reward and medical information. IMPORTANT: By investing in this business you agree to ourDisclaimer. All information including our rating, is provided merely for informational purposes. CryptoTotem does not provide investment advice. |
Overview
|
What is Digital Bio Exchange
Digital BIO Exchange will implement:
Digital BIO Exchange is a biotechnology convergence project created by blockchain developer DGE and REGEN MEDICAL GROUP, the medical specialist organization of South Korea.
Lux BIO Exchange Coin (LBXC) is the recent cryptocurrency in development by DGE, a blockchain development specialist who have developed TMTG. LBXC is the platform cryptocurrency for Digital BIO Exchange platform to enable BIO membership service.
Digital BIO Exchange is planning to establish a stem cell based biotechnology service through various networks of global stem cell treatment service providers and research centers. They will also implement a safe and clean storage service by establishing cell banks dedicated to stem cell storage.
DetailsPre-sales: Oct 15, 2018 - Dec 14, 2018Public sales: Dec 20, 2018 - Jan 20, 2019 Pre-sale token supply: 1,000,000,000 Token supply: 2,000,000,000 Soft cap: 30,000 ETH Hard cap: 62,304,000 USD | Token infoTicker: LBCType: Utility-token Token price in USD: 1 LBC = 0.07896066 USD Accepted currencies: ETH Token distribution: 20% - ICO 18% - Investors & Stockholders 15% - Marketing 15% - Owned by Company 12% - Development Team 10% - Company Reserve 10% - PreSale |
Digital Bio Exchange Roadmap
Private Sale.
Commencement.
Jeju Cell Bank Construction.
1st Pre-Sale (Oct. 15~Nov.14)
Commencement of Japan Stem Cell
Center Construction.
2nd Pre-Sale (Nov. 15~Dec.14).
Public ICO (Dec. 20~Jan.20, 2019)
Japan Center Treatment Launch.
DBE Platform Beta Test.
DBE Platform Open.
Jeju Cell Bank Construction Complete.
Dedicated Accommodation Service.
Project team





































Advisors
